25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

0DHC (Zeiss) Stock Analysis
Buy, Hold or Sell?

Let's analyze Zeiss together

I guess you are interested in Carl Zeiss Meditec AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Zeiss’s Financial Insights
  • 📈 Technical Analysis (TA) – Zeiss’s Price Targets

I'm going to help you getting a better view of Carl Zeiss Meditec AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Carl Zeiss Meditec AG

I send you an email if I find something interesting about Carl Zeiss Meditec AG.

1. Quick Overview

1.1. Quick analysis of Zeiss (30 sec.)










1.2. What can you expect buying and holding a share of Zeiss? (30 sec.)

How much money do you get?

How much money do you get?
€5.14
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€22.99
Expected worth in 1 year
€17.79
How sure are you?
75.0%

+ What do you gain per year?

Total Gains per Share
€-0.81
Return On Investment
-154.5%

For what price can you sell your share?

Current Price per Share
€0.53
Expected price per share
€0.4428 - €0.631
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Zeiss (5 min.)




Live pricePrice per Share (EOD)
€0.53
Intrinsic Value Per Share
€-18.47 - €-22.91
Total Value Per Share
€4.52 - €0.09

2.2. Growth of Zeiss (5 min.)




Is Zeiss growing?

Current yearPrevious yearGrowGrow %
How rich?$2.4b$2.5b-$136.1m-5.7%

How much money is Zeiss making?

Current yearPrevious yearGrowGrow %
Making money$208.9m$339.5m-$130.5m-62.5%
Net Profit Margin8.7%13.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Zeiss (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#26 / 159

Most Revenue
#35 / 159

Most Profit
#30 / 159
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Zeiss?

Welcome investor! Zeiss's management wants to use your money to grow the business. In return you get a share of Zeiss.

First you should know what it really means to hold a share of Zeiss. And how you can make/lose money.

Speculation

The Price per Share of Zeiss is €0.5275. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zeiss.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zeiss, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €22.99. Based on the TTM, the Book Value Change Per Share is €-1.30 per quarter. Based on the YOY, the Book Value Change Per Share is €1.60 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €1.10 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zeiss.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps2.34442.9%2.34442.9%3.80719.7%3.32630.3%3.27619.1%3.27619.1%
Usd Book Value Change Per Share-1.52-288.5%-1.52-288.5%1.87353.9%1.65313.2%6.721,274.1%6.721,274.1%
Usd Dividend Per Share1.28243.4%1.28243.4%1.29243.8%1.21228.9%1.05199.4%1.05199.4%
Usd Total Gains Per Share-0.24-45.2%-0.24-45.2%3.15597.7%2.86542.0%7.771,473.5%7.771,473.5%
Usd Price Per Share0.84-0.84-0.98-1.02-1.25-1.25-
Price to Earnings Ratio0.36-0.36-0.26-0.31-0.39-0.39-
Price-to-Total Gains Ratio-3.51--3.51-0.31--0.99--0.72--0.72-
Price to Book Ratio0.03-0.03-0.03-0.04-0.05-0.05-
Price-to-Total Gains Ratio-3.51--3.51-0.31--0.99--0.72--0.72-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.616753
Number of shares1621
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share1.281.05
Usd Book Value Change Per Share-1.526.72
Usd Total Gains Per Share-0.247.77
Gains per Quarter (1621 shares)-386.0912,599.14
Gains per Year (1621 shares)-1,544.3550,396.57
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
18324-9868-155468194357750387
216648-19736-30981363887155100784
324972-29605-464220457130732151181
433296-39473-618627277174310201578
541619-49341-773034096217887251975
649943-59209-927440915261464302372
758267-69078-1081847734305042352769
866591-78946-1236254553348619403166
974915-88814-1390661372392197453563
1083239-98682-1545068192435774503960

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.01.00.075.0%3.01.00.075.0%3.01.00.075.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.01.00.075.0%3.01.00.075.0%3.01.00.075.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Carl Zeiss Meditec AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.302-1.3020%1.597-182%1.413-192%5.748-123%5.748-123%
Book Value Per Share--22.99322.9930%24.294-5%23.328-1%22.185+4%22.185+4%
Current Ratio--2.1322.1320%3.404-37%2.953-28%3.109-31%3.109-31%
Debt To Asset Ratio--0.3940.3940%0.284+39%0.319+23%0.315+25%0.315+25%
Debt To Equity Ratio--0.6550.6550%0.398+64%0.482+36%0.470+39%0.470+39%
Dividend Per Share--1.0981.0980%1.1000%1.033+6%0.899+22%0.899+22%
Enterprise Value---1272797803.180-1272797803.1800%-785025056.900-38%-918565701.260-28%-831307335.970-35%-831307335.970-35%
Eps--1.9981.9980%3.247-38%2.844-30%2.793-28%2.793-28%
Ev To Sales Ratio---0.616-0.6160%-0.376-39%-0.453-26%-0.426-31%-0.426-31%
Free Cash Flow Per Share--1.0631.0630%1.532-31%1.261-16%1.775-40%1.775-40%
Free Cash Flow To Equity Per Share--1.0631.0630%1.532-31%1.261-16%0.976+9%0.976+9%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---22.907----------
Intrinsic Value_10Y_min---18.469----------
Intrinsic Value_1Y_max--0.495----------
Intrinsic Value_1Y_min--0.481----------
Intrinsic Value_3Y_max---0.639----------
Intrinsic Value_3Y_min---0.565----------
Intrinsic Value_5Y_max---4.337----------
Intrinsic Value_5Y_min---3.808----------
Market Cap47179916.500-35%63923196.82063923196.8200%74995943.100-15%77923632.073-18%95705914.030-33%95705914.030-33%
Net Profit Margin--0.0870.0870%0.139-38%0.127-32%0.131-34%0.131-34%
Operating Margin----0%-0%-0%0.056-100%0.056-100%
Operating Ratio--1.3881.3880%1.254+11%1.280+8%1.257+10%1.257+10%
Pb Ratio0.023-35%0.0310.0310%0.035-10%0.037-17%0.050-38%0.050-38%
Pe Ratio0.264-35%0.3580.3580%0.258+38%0.313+14%0.392-9%0.392-9%
Price Per Share0.528-35%0.7150.7150%0.839-15%0.871-18%1.070-33%1.070-33%
Price To Free Cash Flow Ratio0.496-35%0.6720.6720%0.547+23%0.704-5%0.654+3%0.654+3%
Price To Total Gains Ratio-2.589+26%-3.508-3.5080%0.311-1228%-0.993-72%-0.723-79%-0.723-79%
Quick Ratio--0.3680.3680%0.351+5%1.083-66%1.534-76%1.534-76%
Return On Assets--0.0530.0530%0.096-45%0.084-37%0.088-40%0.088-40%
Return On Equity--0.0880.0880%0.134-35%0.123-29%0.128-31%0.128-31%
Total Gains Per Share---0.204-0.2040%2.697-108%2.446-108%6.648-103%6.648-103%
Usd Book Value--2404435246.8002404435246.8000%2540558187.600-5%2439525277.200-1%2319943008.800+4%2319943008.800+4%
Usd Book Value Change Per Share---1.522-1.5220%1.867-182%1.652-192%6.721-123%6.721-123%
Usd Book Value Per Share--26.88326.8830%28.405-5%27.275-1%25.938+4%25.938+4%
Usd Dividend Per Share--1.2841.2840%1.2860%1.207+6%1.052+22%1.052+22%
Usd Enterprise Value---1488155191.478-1488155191.4780%-917851296.527-38%-1073987017.913-28%-971964537.216-35%-971964537.216-35%
Usd Eps--2.3362.3360%3.796-38%3.325-30%3.266-28%3.266-28%
Usd Free Cash Flow--111208458.000111208458.0000%160180400.000-31%131863545.200-16%185582731.500-40%185582731.500-40%
Usd Free Cash Flow Per Share--1.2431.2430%1.791-31%1.474-16%2.075-40%2.075-40%
Usd Free Cash Flow To Equity Per Share--1.2431.2430%1.791-31%1.474-16%1.141+9%1.141+9%
Usd Market Cap55162758.372-35%74739001.72274739001.7220%87685256.673-15%91108310.620-18%111899354.684-33%111899354.684-33%
Usd Price Per Share0.617-35%0.8360.8360%0.980-15%1.019-18%1.251-33%1.251-33%
Usd Profit--208966439.200208966439.2000%339531003.200-38%297378615.067-30%292097436.100-28%292097436.100-28%
Usd Revenue--2415715688.4002415715688.4000%2442809560.000-1%2361107033.200+2%2252185530.400+7%2252185530.400+7%
Usd Total Gains Per Share---0.238-0.2380%3.153-108%2.859-108%7.772-103%7.772-103%
 EOD+5 -3MRQTTM+0 -0YOY+3 -343Y+6 -315Y+11 -2710Y+11 -27

3.3 Fundamental Score

Let's check the fundamental score of Carl Zeiss Meditec AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.264
Price to Book Ratio (EOD)Between0-10.023
Net Profit Margin (MRQ)Greater than00.087
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.368
Current Ratio (MRQ)Greater than12.132
Debt to Asset Ratio (MRQ)Less than10.394
Debt to Equity Ratio (MRQ)Less than10.655
Return on Equity (MRQ)Greater than0.150.088
Return on Assets (MRQ)Greater than0.050.053
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of Carl Zeiss Meditec AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.454
Ma 20Greater thanMa 500.557
Ma 50Greater thanMa 1000.582
Ma 100Greater thanMa 2000.588
OpenGreater thanClose0.526
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers offers products and solutions for the diagnosis and treatment of chronic eye diseases; and systems and consumables for refractive surgery. This segment also provides slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras used for the examination of the retina in hospitals and practices; and equipment for functional diagnostics. In addition, this segment offers surgical microscopes, biometers, and phacoemulsification or vitrectomy devices; and intraocular lenses for cataract patients. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Fundamental data was last updated by Penke on 2025-07-02 22:42:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Zeiss earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Zeiss to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 8.7% means that €0.09 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Carl Zeiss Meditec AG:

  • The MRQ is 8.7%. The company is making a profit. +1
  • The TTM is 8.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.7%TTM8.7%0.0%
TTM8.7%YOY13.9%-5.2%
TTM8.7%5Y13.1%-4.4%
5Y13.1%10Y13.1%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ8.7%5.0%+3.7%
TTM8.7%4.7%+4.0%
YOY13.9%6.5%+7.4%
3Y12.7%6.4%+6.3%
5Y13.1%6.1%+7.0%
10Y13.1%6.6%+6.5%
4.3.1.2. Return on Assets

Shows how efficient Zeiss is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zeiss to the Medical Instruments & Supplies industry mean.
  • 5.3% Return on Assets means that Zeiss generated €0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Carl Zeiss Meditec AG:

  • The MRQ is 5.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.3%TTM5.3%0.0%
TTM5.3%YOY9.6%-4.3%
TTM5.3%5Y8.8%-3.5%
5Y8.8%10Y8.8%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ5.3%1.0%+4.3%
TTM5.3%1.0%+4.3%
YOY9.6%1.0%+8.6%
3Y8.4%1.2%+7.2%
5Y8.8%1.5%+7.3%
10Y8.8%1.5%+7.3%
4.3.1.3. Return on Equity

Shows how efficient Zeiss is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zeiss to the Medical Instruments & Supplies industry mean.
  • 8.8% Return on Equity means Zeiss generated €0.09 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Carl Zeiss Meditec AG:

  • The MRQ is 8.8%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 8.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ8.8%TTM8.8%0.0%
TTM8.8%YOY13.4%-4.7%
TTM8.8%5Y12.8%-4.0%
5Y12.8%10Y12.8%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ8.8%2.2%+6.6%
TTM8.8%1.9%+6.9%
YOY13.4%1.8%+11.6%
3Y12.3%2.1%+10.2%
5Y12.8%3.0%+9.8%
10Y12.8%2.9%+9.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Carl Zeiss Meditec AG.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Zeiss is operating .

  • Measures how much profit Zeiss makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zeiss to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Carl Zeiss Meditec AG:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y5.6%-5.6%
5Y5.6%10Y5.6%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.0%-8.0%
TTM-6.0%-6.0%
YOY-6.0%-6.0%
3Y-6.7%-6.7%
5Y5.6%8.7%-3.1%
10Y5.6%9.0%-3.4%
4.3.2.2. Operating Ratio

Measures how efficient Zeiss is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.39 means that the operating costs are €1.39 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Carl Zeiss Meditec AG:

  • The MRQ is 1.388. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.388. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.388TTM1.3880.000
TTM1.388YOY1.254+0.134
TTM1.3885Y1.257+0.131
5Y1.25710Y1.2570.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3881.168+0.220
TTM1.3881.131+0.257
YOY1.2541.023+0.231
3Y1.2801.084+0.196
5Y1.2571.053+0.204
10Y1.2571.016+0.241
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Carl Zeiss Meditec AG.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Zeiss is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 2.13 means the company has €2.13 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Carl Zeiss Meditec AG:

  • The MRQ is 2.132. The company is able to pay all its short-term debts. +1
  • The TTM is 2.132. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.132TTM2.1320.000
TTM2.132YOY3.404-1.272
TTM2.1325Y3.109-0.978
5Y3.10910Y3.1090.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1322.053+0.079
TTM2.1322.039+0.093
YOY3.4042.318+1.086
3Y2.9532.380+0.573
5Y3.1092.609+0.500
10Y3.1092.576+0.533
4.4.3.2. Quick Ratio

Measures if Zeiss is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zeiss to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.37 means the company can pay off €0.37 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Carl Zeiss Meditec AG:

  • The MRQ is 0.368. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.368. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.368TTM0.3680.000
TTM0.368YOY0.351+0.017
TTM0.3685Y1.534-1.167
5Y1.53410Y1.5340.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3680.835-0.467
TTM0.3680.948-0.580
YOY0.3511.090-0.739
3Y1.0831.201-0.118
5Y1.5341.425+0.109
10Y1.5341.556-0.022
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Carl Zeiss Meditec AG.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Zeiss assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zeiss to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.39 means that Zeiss assets are financed with 39.4% credit (debt) and the remaining percentage (100% - 39.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Carl Zeiss Meditec AG:

  • The MRQ is 0.394. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.394. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.394TTM0.3940.000
TTM0.394YOY0.284+0.110
TTM0.3945Y0.315+0.079
5Y0.31510Y0.3150.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3940.395-0.001
TTM0.3940.384+0.010
YOY0.2840.357-0.073
3Y0.3190.350-0.031
5Y0.3150.357-0.042
10Y0.3150.374-0.059
4.5.4.2. Debt to Equity Ratio

Measures if Zeiss is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zeiss to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 65.5% means that company has €0.65 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Carl Zeiss Meditec AG:

  • The MRQ is 0.655. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.655. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.655TTM0.6550.000
TTM0.655YOY0.398+0.256
TTM0.6555Y0.470+0.185
5Y0.47010Y0.4700.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6550.606+0.049
TTM0.6550.591+0.064
YOY0.3980.558-0.160
3Y0.4820.580-0.098
5Y0.4700.574-0.104
10Y0.4700.664-0.194
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Zeiss generates.

  • Above 15 is considered overpriced but always compare Zeiss to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 0.36 means the investor is paying €0.36 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Carl Zeiss Meditec AG:

  • The EOD is 0.264. Based on the earnings, the company is cheap. +2
  • The MRQ is 0.358. Based on the earnings, the company is cheap. +2
  • The TTM is 0.358. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.264MRQ0.358-0.094
MRQ0.358TTM0.3580.000
TTM0.358YOY0.258+0.099
TTM0.3585Y0.392-0.035
5Y0.39210Y0.3920.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD0.26415.617-15.353
MRQ0.35814.950-14.592
TTM0.35814.998-14.640
YOY0.25817.237-16.979
3Y0.31318.333-18.020
5Y0.39220.650-20.258
10Y0.39220.725-20.333
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Carl Zeiss Meditec AG:

  • The EOD is 0.496. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 0.672. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 0.672. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.496MRQ0.672-0.176
MRQ0.672TTM0.6720.000
TTM0.672YOY0.547+0.125
TTM0.6725Y0.654+0.018
5Y0.65410Y0.6540.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD0.4969.966-9.470
MRQ0.6729.091-8.419
TTM0.6729.766-9.094
YOY0.5479.099-8.552
3Y0.7044.559-3.855
5Y0.6545.094-4.440
10Y0.6541.765-1.111
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Zeiss is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 0.03 means the investor is paying €0.03 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Carl Zeiss Meditec AG:

  • The EOD is 0.023. Based on the equity, the company is cheap. +2
  • The MRQ is 0.031. Based on the equity, the company is cheap. +2
  • The TTM is 0.031. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.023MRQ0.031-0.008
MRQ0.031TTM0.0310.000
TTM0.031YOY0.035-0.003
TTM0.0315Y0.050-0.019
5Y0.05010Y0.0500.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD0.0232.454-2.431
MRQ0.0312.397-2.366
TTM0.0312.562-2.531
YOY0.0352.695-2.660
3Y0.0372.743-2.706
5Y0.0503.519-3.469
10Y0.0503.925-3.875
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets3,393,200
Total Liabilities1,336,721
Total Stockholder Equity2,041,697
 As reported
Total Liabilities 1,336,721
Total Stockholder Equity+ 2,041,697
Total Assets = 3,393,200

Assets

Total Assets3,393,200
Total Current Assets1,212,483
Long-term Assets2,180,717
Total Current Assets
Cash And Cash Equivalents 20,285
Net Receivables 209,053
Inventory 536,163
Total Current Assets  (as reported)1,212,483
Total Current Assets  (calculated)765,501
+/- 446,982
Long-term Assets
Property Plant Equipment 353,763
Goodwill 982,505
Intangible Assets 706,850
Long-term Assets Other 687
Long-term Assets  (as reported)2,180,717
Long-term Assets  (calculated)2,043,805
+/- 136,912

Liabilities & Shareholders' Equity

Total Current Liabilities568,835
Long-term Liabilities767,886
Total Stockholder Equity2,041,697
Total Current Liabilities
Accounts payable 183,542
Other Current Liabilities 9,672
Total Current Liabilities  (as reported)568,835
Total Current Liabilities  (calculated)193,214
+/- 375,621
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt151,347
Long-term Liabilities Other 18,004
Long-term Liabilities  (as reported)767,886
Long-term Liabilities  (calculated)169,351
+/- 598,535
Total Stockholder Equity
Retained Earnings 1,486,423
Total Stockholder Equity (as reported)2,041,697
Total Stockholder Equity (calculated)1,486,423
+/- 555,274
Other
Capital Stock89,441
Common Stock Shares Outstanding 87,536
Net Invested Capital 2,041,697
Net Working Capital 643,648
Property Plant and Equipment Gross 615,348



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-09-302023-09-302022-09-302021-09-302020-09-302019-09-30
> Total Assets 
0
0
2,395,968
2,822,817
3,032,924
3,393,200
3,393,2003,032,9242,822,8172,395,96800
   > Total Current Assets 
1,304,329
1,293,752
1,604,018
1,791,853
1,911,727
1,212,483
1,212,4831,911,7271,791,8531,604,0181,293,7521,304,329
       Cash And Cash Equivalents 
0
0
7,439
7,729
10,601
20,285
20,28510,6017,7297,43900
       Net Receivables 
999,812
979,126
1,293,696
1,365,268
196,916
209,053
209,053196,9161,365,2681,293,696979,126999,812
       Inventory 
268,322
286,360
286,375
382,745
519,615
536,163
536,163519,615382,745286,375286,360268,322
       Other Current Assets 
4,214
15,396
7,951
23,665
0
0
0023,6657,95115,3964,214
   > Long-term Assets 
0
0
791,950
1,030,964
1,121,197
2,180,717
2,180,7171,121,1971,030,964791,95000
       Property Plant Equipment 
111,132
119,756
199,555
236,145
315,773
353,763
353,763315,773236,145199,555119,756111,132
       Goodwill 
0
0
328,714
429,648
415,783
982,505
982,505415,783429,648328,71400
       Intangible Assets 
0
0
153,698
240,427
259,489
706,850
706,850259,489240,427153,69800
       Long-term Assets Other 
0
0
785
1,189
963
687
6879631,18978500
> Total Liabilities 
0
0
718,585
792,726
860,021
1,336,721
1,336,721860,021792,726718,58500
   > Total Current Liabilities 
339,600
297,584
448,118
539,316
561,646
568,835
568,835561,646539,316448,118297,584339,600
       Accounts payable 
118,120
91,679
145,465
189,185
239,792
183,542
183,542239,792189,185145,46591,679118,120
       Other Current Liabilities 
127,269
117,213
190,240
226,779
4,663
9,672
9,6724,663226,779190,240117,213127,269
   > Long-term Liabilities 
0
0
270,467
253,410
298,375
767,886
767,886298,375253,410270,46700
       Capital Lease Obligations Min Short Term Debt
0
0
121,270
127,903
155,696
151,347
151,347155,696127,903121,27000
       Long-term Liabilities Other 
0
0
14,738
17,445
17,815
18,004
18,00417,81517,44514,73800
       Deferred Long Term Liability 
116,356
123,152
137,120
224,832
0
0
00224,832137,120123,152116,356
> Total Stockholder Equity
0
0
1,659,327
2,015,100
2,159,453
2,041,697
2,041,6972,159,4532,015,1001,659,32700
   Common Stock
89,441
89,441
89,441
89,441
0
0
0089,44189,44189,44189,441
   Retained Earnings Total Equity000000
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
-55,812
-86,783
-50,729
91,632
0
0
0091,632-50,729-86,783-55,812



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-09-30. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue2,066,127
Cost of Revenue-977,497
Gross Profit1,088,6301,088,630
 
Operating Income (+$)
Gross Profit1,088,630
Operating Expense-1,889,776
Operating Income176,351-801,146
 
Operating Expense (+$)
Research Development343,089
Selling General Administrative569,208
Selling And Marketing Expenses0
Operating Expense1,889,776912,297
 
Net Interest Income (+$)
Interest Income23,273
Interest Expense-29,424
Other Finance Cost-44,003
Net Interest Income37,852
 
Pretax Income (+$)
Operating Income176,351
Net Interest Income37,852
Other Non-Operating Income Expenses0
Income Before Tax (EBT)240,866176,351
EBIT - interestExpense = -29,424
178,726
208,150
Interest Expense29,424
Earnings Before Interest and Taxes (EBIT)0270,290
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax240,866
Tax Provision-60,712
Net Income From Continuing Ops180,154180,154
Net Income178,726
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-37,852
 

Technical Analysis of Zeiss
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zeiss. The general trend of Zeiss is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zeiss's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Zeiss Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Carl Zeiss Meditec AG.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.538 < 0.5395 < 0.631.

The bearish price targets are: 0.49 > 0.4512 > 0.4428.

Know someone who trades $0DHC? Share this with them.👇

Carl Zeiss Meditec AG Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Carl Zeiss Meditec AG. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Carl Zeiss Meditec AG Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Carl Zeiss Meditec AG. The current macd is -0.01731929.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zeiss price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Zeiss. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Zeiss price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Carl Zeiss Meditec AG Daily Moving Average Convergence/Divergence (MACD) ChartCarl Zeiss Meditec AG Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Carl Zeiss Meditec AG. The current adx is 21.59.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Zeiss shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Carl Zeiss Meditec AG Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Carl Zeiss Meditec AG. The current sar is 0.56516914.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Carl Zeiss Meditec AG Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Carl Zeiss Meditec AG. The current rsi is 38.45. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Carl Zeiss Meditec AG Daily Relative Strength Index (RSI) ChartCarl Zeiss Meditec AG Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Carl Zeiss Meditec AG. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zeiss price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Carl Zeiss Meditec AG Daily Stochastic Oscillator ChartCarl Zeiss Meditec AG Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Carl Zeiss Meditec AG. The current cci is -97.09365541.

Carl Zeiss Meditec AG Daily Commodity Channel Index (CCI) ChartCarl Zeiss Meditec AG Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Carl Zeiss Meditec AG. The current cmo is -27.99016292.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Carl Zeiss Meditec AG Daily Chande Momentum Oscillator (CMO) ChartCarl Zeiss Meditec AG Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Carl Zeiss Meditec AG. The current willr is -75.97402597.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Zeiss is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Carl Zeiss Meditec AG Daily Williams %R ChartCarl Zeiss Meditec AG Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Carl Zeiss Meditec AG.

Carl Zeiss Meditec AG Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Carl Zeiss Meditec AG. The current atr is 0.01907894.

Carl Zeiss Meditec AG Daily Average True Range (ATR) ChartCarl Zeiss Meditec AG Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Carl Zeiss Meditec AG. The current obv is -1,434,694.

Carl Zeiss Meditec AG Daily On-Balance Volume (OBV) ChartCarl Zeiss Meditec AG Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Carl Zeiss Meditec AG. The current mfi is 78.65.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Carl Zeiss Meditec AG Daily Money Flow Index (MFI) ChartCarl Zeiss Meditec AG Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Carl Zeiss Meditec AG.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-07STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Carl Zeiss Meditec AG Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Carl Zeiss Meditec AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.454
Ma 20Greater thanMa 500.557
Ma 50Greater thanMa 1000.582
Ma 100Greater thanMa 2000.588
OpenGreater thanClose0.526
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Zeiss with someone you think should read this too:
  • Are you bullish or bearish on Zeiss? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zeiss? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Carl Zeiss Meditec AG

I send you an email if I find something interesting about Carl Zeiss Meditec AG.


Comments

How you think about this?

Leave a comment

Stay informed about Carl Zeiss Meditec AG.

Receive notifications about Carl Zeiss Meditec AG in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.